ADMA Biologics Unearned Premium on Insurance Contract (Quarterly) Trends

ADMA Biologics, Inc. (ADMA)

17.63 +0.27 (+1.56%) USD | NASDAQ | Jan 22, 12:59

View Unearned Premium on Insurance Contract (Quarterly) for ADMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Arcutis Biotherapeutics, Inc.	--
Vanda Pharmaceuticals, Inc.	--
Aldeyra Therapeutics, Inc.	--
Marker Therapeutics, Inc.	--
CorMedix, Inc.	--